AAAAAA

   
Results: 1-10 |
Results: 10
Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease
Authors: Killiany, RJ Gomez-Isla, T Moss, M Kikinis, R Sandor, T Jolesz, F Tanzi, R Jones, K Hyman, BT Albert, MS
Citation: Rj. Killiany et al., Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease, ANN NEUROL, 47(4), 2000, pp. 430-439
The human DIMINUTO/DWARF1 homolog seladin-1 confers resistance to Alzheimer's disease-associated neurodegeneration and oxidative stress
Authors: Greeve, I Hermans-Borgmeyer, I Brellinger, C Kasper, D Gomez-Isla, T Behl, C Levkau, B Nitsch, RM
Citation: I. Greeve et al., The human DIMINUTO/DWARF1 homolog seladin-1 confers resistance to Alzheimer's disease-associated neurodegeneration and oxidative stress, J NEUROSC, 20(19), 2000, pp. 7345-7352
Description of microcolumnar ensembles in association cortex and their disruption in Alzheimer and Lewy body dementias
Authors: Buldyrev, SV Cruz, L Gomez-Isla, T Gomez-Tortosa, E Havlin, S Le, R Stanley, HE Urbanc, B Hyman, BT
Citation: Sv. Buldyrev et al., Description of microcolumnar ensembles in association cortex and their disruption in Alzheimer and Lewy body dementias, P NAS US, 97(10), 2000, pp. 5039-5043
Donepezil therapy in clinical practice - A randomized crossover study
Authors: Greenberg, SM Tennis, MK Brown, LB Gomez-Isla, T Hayden, DL Schoenfeld, DA Walsh, KL Corwin, C Daffner, KR Friedman, P Meadows, ME Sperling, RA Growdon, JH
Citation: Sm. Greenberg et al., Donepezil therapy in clinical practice - A randomized crossover study, ARCH NEUROL, 57(1), 2000, pp. 94-99
Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome - Differential effects of APOE genotype and presenilin mutations
Authors: Cataldo, AM Peterhoff, CM Troncosco, JC Gomez-Isla, T Hyman, BT Nixon, RA
Citation: Am. Cataldo et al., Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome - Differential effects of APOE genotype and presenilin mutations, AM J PATH, 157(1), 2000, pp. 277-286
Risperidone treatment of behavioral disturbances in outpatients with dementia
Authors: Irizarry, MC Ghaemi, SN Lee-Cherry, ER Gomez-Isla, T Binetti, G Hyman, BT Growdon, JH
Citation: Mc. Irizarry et al., Risperidone treatment of behavioral disturbances in outpatients with dementia, J NEUROP CL, 11(3), 1999, pp. 336-342
Clinicopathologic correlates in temporal cortex in dementia with Lewy bodies
Authors: Gomez-Isla, T Growdon, WB McNamara, M Newell, K Gomez-Tortosa, E Hedley-Whyte, ET Hyman, BT
Citation: T. Gomez-isla et al., Clinicopathologic correlates in temporal cortex in dementia with Lewy bodies, NEUROLOGY, 53(9), 1999, pp. 2003-2009
Lack of association of presenilin-1 intron-8 polymorphism with neuropathological features of Alzheimer's disease
Authors: Liao, A Gomez-Isla, T Clatworthy, A Hyman, BT
Citation: A. Liao et al., Lack of association of presenilin-1 intron-8 polymorphism with neuropathological features of Alzheimer's disease, BRAIN RES, 816(2), 1999, pp. 295-298
The impact of different presenilin 1 and presenilin 2 mutations on amyloiddeposition, neurofibrillary changes and neuronal loss in the familial Alzheimer's disease brain - Evidence for other phenotype-modifying factors
Authors: Gomez-Isla, T Growdon, WB McNamara, MJ Nochlin, D Bird, TD Arango, JC Lopera, F Kosik, KS Lantos, PL Cairns, NJ Hyman, BT
Citation: T. Gomez-isla et al., The impact of different presenilin 1 and presenilin 2 mutations on amyloiddeposition, neurofibrillary changes and neuronal loss in the familial Alzheimer's disease brain - Evidence for other phenotype-modifying factors, BRAIN, 122, 1999, pp. 1709-1719
A beta associated neuropil changes: Correlation with neuronal loss and dementia
Authors: Knowles, RB Gomez-Isla, T Hyman, BT
Citation: Rb. Knowles et al., A beta associated neuropil changes: Correlation with neuronal loss and dementia, J NE EXP NE, 57(12), 1998, pp. 1122-1130
Risultati: 1-10 |